Persistence of pathogens despite clinical improvement in antibiotic-treated acute otitis media is associated with clinical and bacteriologic relapse

Pediatric Infectious Disease Journal

Volumn 27, Issue 4, 2008, Pages 296-301

  Asher, Elad ^a   Dagan, Ron ^a   Greenberg, David ^a   Givon Lavi, Noga ^a   Libson, Shai ^a   Porat, Nurith ^a   Leiberman, Alberto ^a   Leibovitz, Eugene ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute otitis media; Antibiotic treatment; Persistence; Recurrence

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFTRIAXONE; COTRIMOXAZOLE; GATIFLOXACIN; LEVOFLOXACIN;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GEL ELECTROPHORESIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYRINGOTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT FAILURE;

EID: 41649107685     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e31815ed79c     Document Type: Article

References (28)

1. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antimicrobial agents for acute otitis media: the "Polyanna phenomenon". J Pediatr. 1992;120:72-77.
2. Dagan R, McCracken GH Jr. Flaws in the design and conduct of clinical trials in acute otitis media. Pediatr Infect Dis J. 2002;21:894-902.
3. Marchant CD. Acute otitis media, antibiotics, children and clinical trial designs. Pediatr Infect Dis J. 2002;21:891-3.
4. Carlin SA, Marchant CD, Shurin PA, Johnson CE, Super DM, Rehmus DIM. Host factors and early therapeutic responses in acute otitis media: does symptomatic response correlate with bacterial outcome? J Pediatr. 1991;118:178-183.
5. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17:776-782.
6. Dagan R, Leibovitz E. Bacterial eradication in the treatment of acute otitis media. Lancet Infect Dis. 2002;2:593-604.
7. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneu-mococci with intermediate resistance to penicillin. Pediatr Infect Dis J. 1996;15:980-985.
8. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Inf Dis. 1997;176:1253-1259.
9. Dagan R, Piglansky L, Yagupsky P, et al. Bacteriologic response to acute otitis media: comparison between azythromycin, cefaclor and amoxicillin. In: Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, September 28-October 1, 1997. Washington, DC: American Society of Microbiology; 1997. [Abstract K-103].
10. Leibovitz E, Raiz S, Piglansly L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J. 1998;17:643-649.
11. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in non-responsive acute otitis media. Pediatr Infect Dis J. 1998;17:1126-1131.
12. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother. 2000;44:43-50.
13. Leibovitz E, Piglansky L, Raiz S, et al. The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone in the treatment of nonresponsive acute otitis media. Pediatr Infect Dis J. 2000;19:1040-1045.
14. Dagan R, Johnson C, McLinn S, et al. Bacteriological and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19:95-104.
15. Leiberman A, Leibovitz E, Piglansky L, et al. The bacteriologic and clinical efficacy of trimethoprim/sulfamethoxazole in the treatment of acute otitis media in children. Pediatr Infect Dis J. 2001;20:260-264.
16. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriological and clinical efficacy of oral gatifloxacin in the treatment of recurrent/non-responsive acute otitis media: an open-label, single center, non-comparative, double tympanocentesis study. Pediatr Infect Dis J. 2003;22:1-7.
17. Noel GJ, Leibovitz E, Dagan R, et al. Levofloxacin therapy for infants and young children with persistent or recurrent acute otitis media. In: Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, September 14-17, 2003. Washington, DC: American Society of Microbiology; 2003. [Abstract G-2081].
18. Hobermann A, Dagan R, Leibovitz E, et al. Large dosage amoxicillin/ clavulanate compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J. 2005;24:525-532.
19. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43:699-709.
20. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
21. Pichichero ME. Recurrent and persistent otitis media. Pediatr Infect Dis J. 2000;19:911-916.
22. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001;160:407-413.
23. Arrieta A, Singh J. Management of recurrent and persistent acute otitis media: new options with familiar antibiotics. Pediatr Infect Dis J. 2004;23:s115-s124.
24. Piglansky L, Leibovitz E, Raiz S, et al. The bacteriologic and clinical efficacy of high-dose amoxicillin as first-line therapy for acute otitis media in children. Pediatr Infect Dis J. 2003;22:405-412.
25. Leibovitz E, Greenberg D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J. 2003;22:209-215.
26. Libson S, Dagan R, Greenberg D, et al. Nasopharyngeal carriage of Streptococcus pneumoniae at the completion of successful antibiotic treatment of acute otitis media predisposes to early clinical recurrence. J Infect Dis. 2005;191:1869-1875.
27. Dagan R, Greenberg D, Porat N, et al. The clinical consequences of the selective effect of levofloxacin on carriage of respiratory pathogens in children with persistent or recurrent acute otitis media. In: Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, September 14-17, 2003. Washington, DC: American Society of Microbiology; 2003. [Abstract G-2090].
28. Dagan R, Leibovitz E, Cheletz G, Leiberman A, Porath N. Antibiotic treatment in acute otitis media promotes super-infection with resistant Streptococcus pneumoniae carried before initiation of treatment. J Infect Dis. 2001;183:880-886.